Myeloproliferative Neoplasms: JAK2 Signaling Pathway as a Central Target for Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Myeloproliferative Neoplasms: JAK2 Signaling Pathway as a Central Target for Therapy

Published:2014-09 Issue: Volume:14 Page:S23-S35
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Pasquier Florence,Cabagnols Xenia,Secardin Lise,Plo Isabelle,Vainchenker William

Funder

Institut National de la Santé et de la recherche Médicale

Association nationale de la Recherche (ANR) Blanc

Jeunes chercheurs Jeunes Chercheuses (JCJC)

DIM Stem pole

Association pour la Recherche sur le Cancer (ARC) foundation

Ministere de l'Education Nationale de la Recherche et de Technologie (MENRT)

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference131 articles.

1. The chronic myeloproliferative disorders: clonality and clinical heterogeneity;Spivak;Semin Hematol,2004

2. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders;Baxter;Lancet,2005

3. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera;James;Nature,2005

4. A gain-of-function mutation of JAK2 in myeloproliferative disorders;Kralovics;N Engl J Med,2005

5. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis;Levine;Cancer Cell,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in JAK2 inhibition for the treatment of myelofibrosis;Expert Opinion on Pharmacotherapy;2024-06-12

2. The Tyrosine Kinase-Driven Networks of Novel Long Non-coding RNAs and Their Molecular Targets in Myeloproliferative Neoplasms;Frontiers in Cell and Developmental Biology;2021-08-03

3. Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms;HemaSphere;2021-06-12

4. JAK2V617F myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML;Journal of Experimental Medicine;2020-10-19

5. STAT5 is Expressed in CD34+/CD38− Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms;Cancers;2020-04-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3